Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus–infected Thais from the 2NN Cohort Study

References

• Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, Monforte AD, Wu AW, Starace F (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 45:394–402.
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799.
   PubMed Web of Science ®Google Scholar
• Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B (2001). The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage 21:41–51.
   PubMed Web of Science ®Google Scholar
• Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319.
   PubMed Web of Science ®Google Scholar
• Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F (2006). Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med 7:112–121.
   PubMed Web of Science ®Google Scholar
• Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J NeuroVirol 13:195–202.
   PubMed Web of Science ®Google Scholar
• Heaton R, Franklin D, Clifford D, Woods S, Mindt M, Vigil O, Taylor M, Marcotte T, Atkinson H, GrantI (2009). Abstract 154: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: The CHARTER Study. In: 16th Conference on Retroviruses and Opportunistic Infections, Montreal, CA. February 8-11, 2009.
   Google Scholar
• Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, Street A, Lloyd J, Williams B (2005). Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry 39:826–832.
   PubMed Web of Science ®Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65–70.
   PubMed Web of Science ®Google Scholar
• Liner KJ 2nd, Hall CD, Robertson KR (2007). Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J NeuroVirol 13:291–304.
   PubMed Web of Science ®Google Scholar
• Lotrakul M, Sukanich P (1999). Development of the Thai Depression Inventory. J Med Assoc Thai 82:1200–1207.
   PubMedGoogle Scholar
• Lotrakul M, Sumrithe S, Saipanish R (2008). Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry 8: 46.
   PubMed Web of Science ®Google Scholar
• Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 78:2586–2590.
   PubMed Web of Science ®Google Scholar
• Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915–1921.
   PubMed Web of Science ®Google Scholar
• Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H (2007). Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol 64:1249–1257.
   Google Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 8:136–142.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Nakasujja N, Robertson K, Clifford DB (2007). HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity. Nat Clin Pract Neurol 3:436–443.
   Google Scholar
• Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67:311–314.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC (2009). HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49:780–786.
   PubMed Web of Science ®Google Scholar
• Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V (2005). Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19:45–52.
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45:174–182.
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J NeuroVirol 11:265–273.
   PubMed Web of Science ®Google Scholar
• Valcour VG, Shiramizu BT, Sithinamsuwan P, Nidhinandana S, Ratto-Kim S, Ananworanich J, Siangphoe U, Kim JH, de Souza M, Degruttola V, Paul RH, Shikuma CM (2009). HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 72:992–998.
   PubMed Web of Science ®Google Scholar
• Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, Desouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, Shikuma CM (2007). Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection. Neurology 68:525–527.
   Google Scholar
• van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM (2004). Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet 363:1253–1263.
   PubMed Web of Science ®Google Scholar
• Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71:50–56.
   PubMed Web of Science ®Google Scholar